(+) -Adomeglivant
(+) -Adomeglivant ((+) -LY2409021) is a potent and selective glycogenotropin receptor antagonist with glucose-lowering activity. (+) -Adomeglivant reduces fasting blood glucose levels in both healthy subjects and patients with type 2 diabetes. The use of (+) -Adomeglivant can help investigate the mechanisms of hyperglycemia in type 2 diabetes. The antagonistic effect of (+) -Adomeglivant makes it challenging to assess the metabolic consequences of postprandial hyperglycemia[1].
Product Specifications
CAS Number
872260-19-0
Product Name Alternative
(+) -LY2409021
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/plus-adomeglivant.html
Smiles
O=C(O)CCNC(C1=CC=C([C@H](OC2=CC(C)=C(C3=CC=C(C(C)(C)C)C=C3)C(C)=C2)CCC(F)(F)F)C=C1)=O
Molecular Formula
C32H36F3NO4
Molecular Weight
555.63
References & Citations
[1]The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Klebsiella Pneumoniae pepB Protein (aa 1-428)
PPP2R4 CRISPRa sgRNA lentivector (set of three targets)(Human)
